Chaperone and Age-Related Macular Degeneration Model
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2007 - December 31, 2009
Grant ID
M2007037
Goals
These investigators have established a genetically distinct mouse lineage that develops many features similar to AMD. By studying these mice, the investigators hope to learn more about the causes of AMD and potentially suggest new therapies.
Summary
Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly in the USA and developed countries. Currently, there is no treatment for the disease. AMD results from damage to the retina, a neuronal tissue in the eye that is responsible for vision. We have established a mouse strain that shows many AMD features. We hypothesize that these features may result from the accumulation of certain toxic proteins in retinal cells. We propose to study this mouse model and identify the specific toxic proteins. We plan to find therapies to eliminate these toxic proteins and treat AMD.
Related Grants
Macular Degeneration Research
Storing Fat in the Eye: A Pathway for Tackling AMD
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
John Han, PhD
Current Organization
University of Michigan Medical Center
Storing Fat in the Eye: A Pathway for Tackling AMD
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
John Han, PhD
Current Organization
University of Michigan Medical Center
Macular Degeneration Research
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
The Novel Role of an Intracellular Nuclear Receptor in AMD Pathogenesis
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Neetu Kushwah, PhD
Current Organization
Boston Children’s Hospital
Macular Degeneration Research
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Krishna Singh, PhD
Current Organization
Johns Hopkins University School of Medicine
Exploring How NRF2 Protein Reduces RPE Cell Damage by Cigarette Smoke
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Krishna Singh, PhD
Current Organization
Johns Hopkins University School of Medicine